Institute of Chemical Technology (ICT), Mumbai and its flagship initiative Biosimilar Workshop: Digital Edition will be conducting a workshop focussed on COVID-19, in virtual mode from October 4-8, 2021, as a four-part webinar series organised over 5 days.

The workshop will impart training and insight directly from experts and academicians of the biopharmaceutical, diagnostic and vaccine industries on crucial steps and details of the latest research and development taking place in the respective fields.

The workshop commenced in 2017 as an annual endeavour to stimulate and encourage discussion as well as innovation of new technologies in various sectors of the biopharmaceutical industry.

Keeping in mind the unprecedented changes brought to the world due to the SARS-CoV-2 pandemic, the 2021 Digital Edition of the Biosimilar Workshop aims to enlighten all participants on the recent research in diagnosis, therapeutic interventions and analytical characterisation of the SARS-CoV-2 virus.

This year, the biosimilar workshop will have leaders from the biopharmaceutical field, who will provide a seasoned perspective on topics such as: structural analysis of the SARS-CoV-2 spike protein pre/post-fusion conformations and interactions with ACE2 or neutralising antibodies; Site-Specific Steric Control of SARS-CoV-2 Spike Glycosylation; Reading and writing the genome with precision; The journey of India's first indigenous SARS-CoV-2 vaccine (Covaxin), to name a few.